Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunocompromised Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00026767
What this trial is testing

Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients

Who this might be right for
Fungus Disease
National Cancer Institute (NCI) 217
Not applicableStudy completedNCT00998803
What this trial is testing

Surveillance of Influenza Virus Shedding and Immunologic Response in Immunocompromised Children and Young Adults

Who this might be right for
Influenza Virus
St. Jude Children's Research Hospital 9
Not applicableEnded earlyNCT05655546
What this trial is testing

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Who this might be right for
ImmunodeficiencyImmunosuppressionHIV Infections+7 more
Scripps Translational Science Institute 2,117
Large-scale testing (Phase 3)Looking for participantsNCT07013474
What this trial is testing

Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Who this might be right for
COVID-19 Infection
Pfizer 300
Large-scale testing (Phase 3)Study completedNCT01466062
What this trial is testing

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 28
Not applicableNot Yet RecruitingNCT07674550
What this trial is testing

Biological Collection on Emerging Infectious Diseases and Their Treatments

Who this might be right for
Emerging Infectious Diseases and Their Treatments
University Hospital, Toulouse 5,300
Testing effectiveness (Phase 2)Study completedNCT01685372
What this trial is testing

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Who this might be right for
Solid Organ Transplant Recipient (Liver, Kidney, Heart)Rheumatologic DisorderHuman Immunodeficiency Virus (HIV)+2 more
University of Colorado, Denver 16
Testing effectiveness (Phase 2)Temporarily pausedNCT01887457
What this trial is testing

Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy

Who this might be right for
Immunocompromised PatientAspergillosisFusarium
Brynn Chappell 33
Not applicableAvailableNCT05844436
What this trial is testing

Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

Who this might be right for
HSV
AiCuris Anti-infective Cures AG
Not applicableLooking for participantsNCT06387667
What this trial is testing

Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections

Who this might be right for
Immunocompromised ICU Patients With Respiratory Tract Infections
New Valley University 250
Not applicableStudy completedNCT00002132
What this trial is testing

Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

Who this might be right for
Candidiasis, EsophagealHIV Infections
Janssen Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01935531
What this trial is testing

Effects of Topical Diclofenac on Tumor Metabolism

Who this might be right for
Actinic Keratoses
University Hospital Regensburg 38
Not applicableLooking for participantsNCT06755814
What this trial is testing

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)

Who this might be right for
Community Acquired Pneumonia (CAP)
Societa Italiana di Pneumologia 1,298
Not applicableNot Yet RecruitingNCT06709157
What this trial is testing

Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients

Who this might be right for
Tuberculosis
Sohag University 200
Large-scale testing (Phase 3)UnknownNCT04680884
What this trial is testing

Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled Trial

Who this might be right for
Acute Respiratory FailureImmunocompromised Patients
Assistance Publique - Hôpitaux de Paris 420
Early research (Phase 1)Ended earlyNCT01716234
What this trial is testing

The Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)

Who this might be right for
Fungal Infections
Merck Sharp & Dohme LLC 142
Not applicableStudy completedNCT03553472
What this trial is testing

Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster

Who this might be right for
Herpes ZosterInflammatory Bowel DiseasesCrohn Disease+1 more
University of Wisconsin, Madison 97
Large-scale testing (Phase 3)Study completedNCT03073967
What this trial is testing

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Who this might be right for
HSV Infection
AiCuris Anti-infective Cures AG 158
Early research (Phase 1)Study completedNCT00535236
What this trial is testing

An Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

Who this might be right for
Herpes ZosterHerpes Zoster-related Complications
Merck Sharp & Dohme LLC 341
Testing effectiveness (Phase 2)Ended earlyNCT05705167
What this trial is testing

Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA)

Who this might be right for
COVID-19
PharmaMar 37
Next Page